Skip to content
Home/Companies/Biotech/Tenpoint Therapeutics
Tenpoint Therapeutics

Tenpoint Therapeutics

Biotech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Tenpoint Therapeutics?

Tenpoint Therapeutics is currently owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage), since 2022. Across its history, Tenpoint Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Websitetenpointtherapeutics.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners and AdBio Partners since 2022.
Co-invest · 2 holders · 2022 · present
Sofinnova Partners
Sofinnova PartnersActive
2022 · present(4yr) · Sofinnova Capital X · 2021 · Life Sciences VC
AdBio Partners
AdBio PartnersActive
2023 · present(3yr) · AFB Fund II · 2021 · VC

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals
Active
BiotechGermany· 2023
Freya Biosciences
Freya Biosciences
Active
BiotechDenmark· 2023
May Health
May Health
Active
MedTechFrance· 2023
Nuage Therapeutics
Nuage Therapeutics
Active
BiotechSpain· 2023
T-Therapeutics
T-Therapeutics
Active
BiotechUK· 2023
Catamaran Bio
Catamaran Bio
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Tenpoint Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Tenpoint Therapeutics?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Tenpoint Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue